Archives: Agenda

• Discover how to leverage indulgence and added functionalities to enhance the perception of product value
• Explore whether indulgence and health-focused functionalities can coexist within the same market demand space
• Identify the most influential product claims

Join this expert-led, peer-to-peer deep-dive session to hear from those in the know. Take back to your business an understanding of what it takes to succeed and lessons learned from those who have been there, done that.

Delegates must pre-register interest prior to the day of the event.

HOSTED BY: Magda Dziuba, Senior Commercial Analyst, Consumer Division, GlobalData

• 3 separate fires beneath the industry’s feet

– Volume decline – the industry faces significant headwinds e.g. moderation, changes in socialising, macro-economic pressure

– Threats from non traditional players e.g. Coca-Cola and PepsiCo?

– GLP – 1 – Is it the single biggest threat to beer and cider consumption in our lifetime?

• Which flame is burning hottest under YOUR business right now and how must the industry adapt to thrive?

Join this expert-led, peer-to-peer deep-dive session to hear from those in the know. Take back to your business an understanding of what it takes to succeed and lessons learned from those who have been there, done that.

Delegates must pre-register interest prior to the day of the event.

HOSTED BY: William Blackett, Director of Consulting, GlobalData

• Authenticity and innovation – lessons from cider’s biggest market
• Zero alcohol, flavours and fruit, abv – how range recruits.
• Occasion and drinker demographics.
• Market trends, opportunities and the future

• Introducing the LogiCO2 Safety System
• If CO2 is part of your operation, safety should be part of your setup

• Exemption list and mandatory list
• Regulations for clinical investigation
• Interaction with registration timeline
• Differences in EU and China

• Eclevar delivers ultra-specialized MedTech CRO services in Cardiovascular, Wound, and Orthopaedic areas, easing clinical trials with expert compliance and cost-effective strategies
• Milo empowers tech-enabled solutions like EDC, eCOA, and innovative patient screening identification, reducing complexity and accelerating trial processes for smarter outcomes

• See how to align robust clinical evidence for MDR from an NB perspective
• Bridge the gap between reviewer expectations and sponsor realities
• Optimize clinical trial design and submissions for smoother approval

Chair: Dominic Tong, Senior Analyst, Medical Devices, GlobalData